Weight-loss drugs like Ozempic and Mounjaro are currently available in the form of injectables. If Eli Lilly's new trials are ...

I N recent months makers of weight-loss drugs have gone on a crash diet. In late July Novo Nordisk, the Danish firm that gave ...

Some health experts say Cassidy deserves blame for CDC turmoil as a doctor who was concerned about Kennedy’s vaccine views ...

Medicare Part D beneficiaries experienced a large increase in out-of-pocket spending for GLP-1s in 2025, according to ...

Gates Foundation and Novo Nordisk Novo Nordisk Foundation have extended the Acetate Consortium initiative with a $25.6M ...

( NewsNation) — New research has revealed that oral semaglutide can help with significant weight loss, with one in three ...

Because of its size, the drugmaker has an outsize effect on the country. Now, as it sheds jobs, forecasts for Denmark’s ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030.

Online pharmacies are using a loophole to continue selling cheap weight loss drugs that are modeled on Ozempic and Mounjaro, ...

A large clinical trial found that a daily semaglutide pill produced significant weight loss and health benefits comparable to injectable versions, setting the stage for possible FDA approval later ...

An experimental GLP-1 pill called orforglipron promoted substantial weight loss without the need for weekly injections, ...